Assembly of Human Papillomavirus 16 L1 Protein in Nicotiana benthamiana Chloroplasts into Highly Immunogenic Virus-Like Particles

[1]  W. Phoolcharoen,et al.  Harnessing the Potential of Plant Expression System towards the Production of Vaccines for the Prevention of Human Papillomavirus and Cervical Cancer , 2022, Vaccines.

[2]  Xifeng Li,et al.  Maximizing the Production of Recombinant Proteins in Plants: From Transcription to Protein Stability , 2022, International journal of molecular sciences.

[3]  I. Hwang,et al.  Plant produced endotoxin binding recombinant proteins effectively remove endotoxins from protein samples , 2022, Scientific Reports.

[4]  L. McKinnon,et al.  HPV and the Risk of HIV Acquisition in Women , 2022, Frontiers in Cellular and Infection Microbiology.

[5]  N. Reynolds,et al.  Cost and effectiveness of HPV vaccine delivery strategies: A systematic review , 2022, Preventive medicine reports.

[6]  Hamid Aria,et al.  An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy , 2022, Frontiers in Immunology.

[7]  Dong Wook Lee,et al.  Functional Organization of Sequence Motifs in Diverse Transit Peptides of Chloroplast Proteins , 2021, Frontiers in Physiology.

[8]  M. Ávila,et al.  Human papillomavirus-independent cervical cancer , 2021, International Journal of Gynecological Cancer.

[9]  Zigui Chen,et al.  Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asia , 2021, Cancers.

[10]  I. Hwang,et al.  Plant-based, adjuvant-free, potent multivalent vaccines for avian influenza virus via Lactococcus surface display. , 2021, Journal of integrative plant biology.

[11]  G. Ahmadian,et al.  Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers , 2021, Journal of Nanobiotechnology.

[12]  T. Jin,et al.  Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation , 2021, Frontiers in Public Health.

[13]  E. Rybicki,et al.  Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs) , 2020, Vaccines.

[14]  I. Hwang,et al.  In Vivo Removal of N-Terminal Fusion Domains From Recombinant Target Proteins Produced in Nicotiana benthamiana , 2020, Frontiers in Plant Science.

[15]  Youn-Il Park,et al.  Development of Systems for the Production of Plant-Derived Biopharmaceuticals , 2019, Plants.

[16]  I. Hwang,et al.  Cost‐effective production of tag‐less recombinant protein in Nicotiana benthamiana , 2018, Plant biotechnology journal.

[17]  Dong Wook Lee,et al.  Evolution and Design Principles of the Diverse Chloroplast Transit Peptides , 2018, Molecules and cells.

[18]  E. Rybicki,et al.  Therapeutic vaccines for high-risk HPV-associated diseases , 2017, Papillomavirus research.

[19]  S. Graham.  The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. , 2017, Clinical science.

[20]  K. Hefferon.  Reconceptualizing cancer immunotherapy based on plant production systems , 2017, Future science OA.

[21]  Hong-Jin Kim,et al.  Characterization of human papillomavirus type 16 pseudovirus containing histones , 2016, BMC Biotechnology.

[22]  Donald M Miller,et al.  Scalable Production of HPV16 L1 Protein and VLPs from Tobacco Leaves , 2016, PloS one.

[23]  Kay M. Johnson,et al.  HPV Update: Vaccination, Screening, and Associated Disease , 2016, Journal of General Internal Medicine.

[24]  N. Lin,et al.  A transgenic plant cell-suspension system for expression of epitopes on chimeric Bamboo mosaic virus particles. , 2016, Plant biotechnology journal.

[25]  Dong Wook Lee,et al.  Sequence Motifs in Transit Peptides Act as Independent Functional Units and Can Be Transferred to New Sequence Contexts1[OPEN] , 2015, Plant Physiology.

[26]  D. Görlich,et al.  A new set of highly efficient, tag-cleaving proteases for purifying recombinant proteins. , 2014, Journal of chromatography. A.

[27]  Dong Wook Lee,et al.  The immediate upstream region of the 5′-UTR from the AUG start codon has a pronounced effect on the translational efficiency in Arabidopsis thaliana , 2013, Nucleic acids research.

[28]  E. Rybicki,et al.  Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras. , 2013, Plant biotechnology journal.

[29]  J. Pezacki,et al.  Studying the RNA silencing pathway with the p19 protein , 2013, FEBS letters.

[30]  E. Rybicki,et al.  Virus-like particles produced in plants as potential vaccines , 2013, Expert review of vaccines.

[31]  Qiang Chen,et al.  Plant-derived virus-like particles as vaccines , 2013, Human vaccines & immunotherapeutics.

[32]  Michael D. McLean,et al.  Utility of the P19 suppressor of gene-silencing protein for production of therapeutic antibodies in Nicotiana expression hosts. , 2012, Plant biotechnology journal.

[33]  S. Kim,et al.  One-step chromatographic purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae. , 2010, Protein expression and purification.

[34]  H. Krishnan,et al.  A rapid method for depletion of Rubisco from soybean (Glycine max) leaf for proteomic analysis of lower abundance proteins. , 2009, Phytochemistry.

[35]  H. Daniell,et al.  Plant-made vaccine antigens and biopharmaceuticals , 2009, Trends in Plant Science.

[36]  M. L. Mora-García,et al.  An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice , 2009, Virology Journal.

[37]  J. M. Seguí-Simarro,et al.  Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic. , 2008, Plant biotechnology journal.

[38]  Marquette Method,et al.  EFFICACY OF THE , 2008 .

[39]  Henry C Kitchener,et al.  Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial , 2007, The Lancet.

[40]  Eduardo Lazcano-Ponce,et al.  Safety and Persistent Immunogenicity of a Quadrivalent Human Papillomavirus Types 6, 11, 16, 18 L1 Virus-Like Particle Vaccine in Preadolescents and Adolescents: A Randomized Controlled Trial , 2007, The Pediatric infectious disease journal.

[41]  R. Birch,et al.  Heterologous signals allow efficient targeting of a nuclear-encoded fusion protein to plastids and endoplasmic reticulum in diverse plant species. , 2007, Plant biotechnology journal.

[42]  Dong Wook Lee,et al.  Functional Characterization of Sequence Motifs in the Transit Peptide of Arabidopsis Small Subunit of Rubisco1[W] , 2005, Plant Physiology.

[43]  A. Rose.  The effect of intron location on intron-mediated enhancement of gene expression in Arabidopsis. , 2004, The Plant journal : for cell and molecular biology.

[44]  Valerian V Dolja,et al.  Viral RNA silencing suppressors inhibit the microRNA pathway at an intermediate step. , 2004, Genes & development.

[45]  I. Hwang,et al.  In vivo import experiments in protoplasts reveal the importance of the overall context but not specific amino acid residues of the transit peptide during import into chloroplasts. , 2002, Molecules and cells.

[46]  H. Hausen.  Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature Reviews Cancer.

[47]  S. Harrison,et al.  Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. , 2000, Molecular cell.

[48]  W. White,et al.  Quantitative Disassembly and Reassembly of Human Papillomavirus Type 11 Viruslike Particles In Vitro , 1998, Journal of Virology.